HHM Wealth Advisors LLC Acquires New Holdings in Encompass Health Co. (NYSE:EHC)

HHM Wealth Advisors LLC bought a new position in Encompass Health Co. (NYSE:EHC) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,700 shares of the company’s stock, valued at approximately $146,000.

Several other hedge funds have also modified their holdings of the company. Coldstream Capital Management Inc. raised its stake in shares of Encompass Health by 1.9% during the 2nd quarter. Coldstream Capital Management Inc. now owns 26,548 shares of the company’s stock worth $2,278,000 after acquiring an additional 488 shares in the last quarter. Daiwa Securities Group Inc. purchased a new position in Encompass Health in the second quarter worth $60,000. Texas Permanent School Fund Corp increased its position in shares of Encompass Health by 8.1% during the second quarter. Texas Permanent School Fund Corp now owns 94,794 shares of the company’s stock worth $8,132,000 after purchasing an additional 7,064 shares in the last quarter. Quest Partners LLC lifted its holdings in shares of Encompass Health by 675.2% during the 2nd quarter. Quest Partners LLC now owns 16,125 shares of the company’s stock valued at $1,383,000 after purchasing an additional 14,045 shares during the last quarter. Finally, Acadian Asset Management LLC acquired a new stake in shares of Encompass Health in the 2nd quarter worth $901,000. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Trading Up 0.1 %

Shares of Encompass Health stock opened at $91.72 on Thursday. The stock has a market cap of $9.23 billion, a PE ratio of 24.79, a price-to-earnings-growth ratio of 1.40 and a beta of 0.88. The firm has a fifty day moving average price of $89.01 and a 200 day moving average price of $84.45. Encompass Health Co. has a 1 year low of $57.55 and a 1 year high of $94.38. The company has a debt-to-equity ratio of 1.08, a current ratio of 1.35 and a quick ratio of 1.35.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Monday, August 5th. The company reported $1.11 earnings per share for the quarter, beating analysts’ consensus estimates of $1.01 by $0.10. Encompass Health had a return on equity of 17.83% and a net margin of 7.88%. The business had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.30 billion. During the same quarter last year, the business posted $0.95 EPS. The company’s revenue was up 9.6% on a year-over-year basis. Equities research analysts predict that Encompass Health Co. will post 4.17 earnings per share for the current year.

Encompass Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Tuesday, October 1st will be given a $0.17 dividend. The ex-dividend date is Tuesday, October 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.74%. This is an increase from Encompass Health’s previous quarterly dividend of $0.15. Encompass Health’s dividend payout ratio is 18.38%.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on EHC shares. Royal Bank of Canada increased their price target on Encompass Health from $83.00 to $95.00 and gave the company an “outperform” rating in a research note on Wednesday, May 22nd. Truist Financial increased their price objective on shares of Encompass Health from $100.00 to $104.00 and gave the company a “buy” rating in a research report on Thursday, August 15th. Stephens reissued an “overweight” rating and set a $105.00 target price on shares of Encompass Health in a research report on Tuesday, August 6th. Leerink Partnrs upgraded shares of Encompass Health to a “strong-buy” rating in a research note on Wednesday, July 10th. Finally, UBS Group boosted their price objective on shares of Encompass Health from $96.00 to $100.00 and gave the company a “buy” rating in a report on Thursday, August 8th. Nine equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $100.38.

Insider Transactions at Encompass Health

In related news, CFO Douglas E. Coltharp sold 12,260 shares of the company’s stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $86.34, for a total value of $1,058,528.40. Following the completion of the transaction, the chief financial officer now owns 136,227 shares of the company’s stock, valued at approximately $11,761,839.18. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 2.10% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.